We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASUR icon
3101
Asure Software
ASUR
$250M
$308K ﹤0.01%
43,354
-271
-0.6% -$2.07K
UBFO
3102
DELISTED
United Security Bancshares
UBFO
$307K ﹤0.01%
43,646
+743
+2% +$5.01K
CHS
3103
DELISTED
Chicos FAS, Inc.
CHS
$305K ﹤0.01%
191,671
PBFS icon
3104
Pioneer Bancorp
PBFS
$434M
$304K ﹤0.01%
28,773
+726
+3% +$7.3K
MRLN
3105
DELISTED
Marlin Business Services Corp
MRLN
$304K ﹤0.01%
24,881
+827
+3% +$8.07K
BEST
3106
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$303K ﹤0.01%
7,415
-10,595
-59% -$566K
CCB icon
3107
Coastal Financial
CCB
$693M
$302K ﹤0.01%
14,377
LOMA
3108
Loma Negra
LOMA
$1.22B
$302K ﹤0.01%
49,083
-5,800
-11% -$29.8K
REFR icon
3109
Research Frontiers
REFR
$17M
$302K ﹤0.01%
107,480
-527
-0.5% -$1.49K
CHNGU
3110
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
0
STEX
3111
Streamex Corp
STEX
$83M
$301K ﹤0.01%
7,731
+121
+2% +$5.32K
MTL
3112
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$301K ﹤0.01%
146,980
-11,300
-7% -$17.8K
CEMI
3113
DELISTED
Chembio diagnostics, Inc.
CEMI
$300K ﹤0.01%
63,272
-109,275
-63% -$564K
CDAK
3114
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$295K ﹤0.01%
+9,141
New +$121K
ACWI icon
3115
iShares MSCI ACWI ETF
ACWI
$33.5B
$294K ﹤0.01%
+3,237
New +$276K
MRKR icon
3116
Marker Therapeutics
MRKR
$18.7M
$285K ﹤0.01%
19,641
-74
-0.4% -$1.15K
EOLS icon
3117
Evolus
EOLS
$501M
$284K ﹤0.01%
84,377
-6,807
-7% -$25.6K
PCB icon
3118
PCB Bancorp
PCB
$391M
$284K ﹤0.01%
28,055
-10,741
-28% -$110K
WRAP icon
3119
Wrap Technologies
WRAP
$104M
$282K ﹤0.01%
58,327
+22,565
+63% +$131K
RVLP
3120
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$281K ﹤0.01%
68,015
PAA icon
3121
Plains All American Pipeline
PAA
$16.1B
$279K ﹤0.01%
33,852
-3,225
-9% -$24.5K
FNHC
3122
DELISTED
FedNat Holding Company Common Stock
FNHC
$279K ﹤0.01%
47,044
+797
+2% +$4.55K
ET icon
3123
Energy Transfer Partners
ET
$69.3B
$278K ﹤0.01%
44,914
+533
+1% +$3.23K
MNSB icon
3124
MainStreet Bancshares
MNSB
$172M
$275K ﹤0.01%
16,274
FVCB icon
3125
FVCBankcorp
FVCB
$333M
$274K ﹤0.01%
23,335

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.